(1)
COST-EFFECTIVENESS ANALYSIS OF USING METFORMIN AND GLIMEPIRIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN YOGYAKARTA, INDONESIA. SEATROPH 2025, 55 (Suppl 1), 107-122.